Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 27061 AL 27075

Implication of Central β(2) Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease

Wang A, Since M, Dallemagne P, Rochais C.

Arch Pharm (Weinheim). 2025 Apr;358(4):e2400750. doi: 10.1002/ardp.202400750.

Exploring the nexus: Sleep disorders, circadian dysregulation, and Alzheimer's disease

Khandayataray P, Murthy MK.

Neuroscience. 2025 May 14;574:21-41. doi: 10.1016/j.neuroscience.2025.03.066. Epub 2025 Apr 4.

The mechanism underlying streptozotocin injection for the development of a nontransgenic Alzheimer's disease animal model

Titisari N, Ahmad H, Samsulrizal N, Fauzi A, Abdul Razak IS.

Open Vet J. 2025 Feb;15(2):594-600. doi: 10.5455/OVJ.2025.v15.i2.8. Epub 2025 Feb 28.

Harnessing marine resources for Alzheimer's therapy: A review integrating bioactivity and molecular docking

Khalid H, Mohamed H, Eltoukhy A, Saeed MT, Song Y.

Eur J Pharmacol. 2025 Jun 15;997:177611. doi: 10.1016/j.ejphar.2025.177611. Epub 2025 Apr 9.

Exploring Retinal Neurodegeneration in Alzheimer's Disease: A Molecular and Cellular Perspective

Dhapola R, Sharma P, Kumari S, Vellingiri B, Medhi B, HariKrishnaReddy D.

Neurotox Res. 2025 Apr 12;43(2):22. doi: 10.1007/s12640-025-00744-4.

Potential Benefits of Quercetin through P2X7 Modulation against Neuroinflammation in Alzheimer's Disease

Bianchini MC, Franscescon F, Soares AA, Ansolin V, Pretto KP, da Cunha MLV, de Resende E Silva DT.

Curr Neuropharmacol. 2025;23(11):1367-1379. doi: 10.2174/011570159X355614250130100132.

Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's Disease

Ozturk B, Demir H, Gunay MS, Akdag Y, Sahin S, Gulsun T.

Curr Neuropharmacol. 2025;23(14):1985-2003. doi: 10.2174/011570159X370790250317045223.

Past, present, and future of serotonin-targeting therapeutics for Alzheimer's disease: Perspectives from DNA methylation

Liu Y, Aquili L, Wong KH, Lu Z, Lim LW.

Ageing Res Rev. 2025 Jun;108:102755. doi: 10.1016/j.arr.2025.102755. Epub 2025 Apr 14.

Impact of corticoid receptors on Alzheimer's disease: a neuroendocrine perspective

Goel F, Kumar D, Sharma A.

Inflammopharmacology. 2025 May;33(5):2641-2656. doi: 10.1007/s10787-025-01734-w. Epub 2025 Apr 18.

NLRP3 inflammasome in Alzheimer's disease: molecular mechanisms and emerging therapies

Li Z, Gong C.

Front Immunol. 2025 Apr 7;16:1583886. doi: 10.3389/fimmu.2025.1583886. eCollection 2025.

Butyrate: a key mediator of gut-brain communication in Alzheimer's disease

Kachoueiyan F, Kalkhoran NY, Kalkhoran AY, Kyada A, Rekha MM, Chaudhary K, Barwal A, Sead FF, Joshi KK.

Metab Brain Dis. 2025 Apr 23;40(5):189. doi: 10.1007/s11011-025-01617-7.

Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunities

Belaidi AA, Bush AI, Ayton S.

Mol Neurodegener. 2025 Apr 24;20(1):47. doi: 10.1186/s13024-025-00843-y.

Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement - Current insights and future perspectives

Mondal R, Deb S, Shome G, Sarkar V, Lahiri D, Datta SS, Benito-León J.

Neurologia (Engl Ed). 2025 Apr;40(3):306-328. doi: 10.1016/j.nrleng.2025.03.008.

Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer's disease: a focus on signaling mechanisms

Han J, Zhang X, Kang L, Guan J.

J Neuroinflammation. 2025 Apr 25;22(1):120. doi: 10.1186/s12974-025-03443-1.

Iatrogenic Dementia: Providing Insight into Transmissible Subtype of Alzheimer's Disease, Creutzfeldt-Jakob Disease and Cerebral Amyloid Angiopathy

Karatzetzou S, Ioannidis S, Konstantinopoulou E, Parisis D, Afrantou T, Ioannidis P.

Biomolecules. 2025 Apr 3;15(4):522. doi: 10.3390/biom15040522.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias